Pharmaceutical

Sanofi signs $1.2bn licensing agreement for Novavax’s Covid-19 vaccine

Sanofi has signed a $1.2bn licensing agreement with Novavax to co-commercialise its stand-alone adjuvanted Covid-19 vaccine.

May 11, 2024 - 04:00
Sanofi signs $1.2bn licensing agreement for Novavax’s Covid-19 vaccine
Sanofi has signed a $1.2bn licensing agreement with Novavax to co-commercialise its stand-alone adjuvanted Covid-19 vaccine.
Read the original article

Tags:

Previous Article

“What was that?” — How brains convert sounds to actions

Next Article

RAPT terminates Phase II trials for lead candidate following clinical hold

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Opinion: How the Wegovy shortage is making life impossible for my patients — and for me

Opinion: How the Wegovy shortage is making life impossi...

Sep 16, 2023

Gilead signs agreements to facilitate access to HIV prevention drug

Gilead signs agreements to facilitate access to HIV pre...

Oct 4, 2024

Abortion policy in the spotlight, DeSantis’ importation showdown, and new price hike analysis

Abortion policy in the spotlight, DeSantis’ importation...

Aug 25, 2023